blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

How to select the right patient registry for your clinical trial

Patient registries, sometimes called patient databases, are a useful tool in any clinical trial patient recruitment strategy. They help researchers identify pot...
Continue reading

Clinical trial recruitment: Parkinson’s channel mix

Clinical trials play a critical role in developing new treatments and therapies for Parkinson's disease, an age-related degenerative brain condition that causes...
Continue reading

Sano x Benevolent AI: Combining machine learning with medical data

Over the past year, Sano and BenevolentAI have collaborated to demonstrate how an integrated, decentralized platform — combining patient recruitment, at-home ge...
Continue reading

Webinar recap: How can applying a "rare disease mindset" accelerate and de-risk precision medicine trials?

In a this webinar, Patrick Short, CEO and co-founder of Sano Genetics, and Patti Engel, CEO of Engage Health, discussed how applying a “rare disease mindset” ca...
Continue reading

Challenges with relying on site databases and patient recruitment companies

Recruiting patients for clinical trials is a crucial component of the drug development process, and a key factor in determining the success or failure of a stud...
Continue reading

CMO Summit 360: Reflections on understanding patient populations, the role of advocacy, and diversity in medical research

Earlier this month, our team had the pleasure of attending the CMO Summit 360 in Boston. This event brought together top-level medical executives and experts fr...
Continue reading

Sano's solutions to drive clinical trials in precision medicine forward

Precision medicine represents a fundamental shift in how therapies are developed and delivered. Rather than designing treatments for the average patient, it tak...
Continue reading

18 patient engagement solutions for trial retention

Patient retention remains one of the most persistent constraints in clinical trial execution. When a significant proportion of enrolled patients drop out before...
Continue reading

Webinar recap: An insider’s view on drug development in MASH with Dimitar Tonev

MASH (Metabolic dysfunction-associated steatohepatitis) is a chronic liver disease that has gained significant attention from the pharmaceutical industry and cl...
Continue reading

Webinar recap: Decentralized clinical trials

Decentralized and hybrid clinical trials hold significant promise for improving access and reducing patient burden. But implementing them introduces operational...
Continue reading